{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T05:15:51Z","timestamp":1717391751605},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Dimeric human erythropoietin (dHuEPO) peptides are reported to exhibit significantly higher biological activity than the monomeric form of recombinant EPO. The objective of this study was to produce transgenic (tg) mice expressing dHuEPO and to investigate the characteristics of these mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A dHuEPO-expressing vector under the control of the goat beta-casein promoter, which produced a dimer of human EPO molecules linked by a 2-amino acid peptide linker (Asp-Ile), was constructed and injected into 1-cell fertilized embryos by microinjection. Mice were screened using genomic DNA samples obtained from tail biopsies. Blood samples were obtained by heart puncture using heparinized tubes, and hematologic parameters were assessed. Using the microarray analysis tool, we analyzed differences in gene expression in the spleens of tg and control mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A high rate of spontaneous abortion or death of the offspring was observed in the recipients of dHuEPO embryos. We obtained 3 founder lines (#4, #11, and #47) of tg mice expressing the<jats:italic>dHuEPO<\/jats:italic>gene. However, only one founder line showed stable germline integration and transmission, subsequently establishing the only transgenic line (#11). We obtained 2 F1 mice and 3 F2 mice from line #11. The dHuEPO protein could not be obtained because of repeated spontaneous abortions in the tg mice. Tg mice exhibited symptoms such as short lifespan and abnormal blood composition. The red blood cell count, white blood cell count, and hematocrit levels in the tg mice were remarkably higher than those in the control mice. The spleens of the tg mice (F1 and F2 females) were 11- and -21-fold larger than those of the control mice. Microarray analysis revealed 2,672 spleen-derived candidate genes; more genes were downregulated than upregulated (849\/764). Reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative real-time PCR (qRT-PCR) were used for validating the results of the microarray analysis of mRNA expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In conclusion, dHuEPO tg mice caused excessive erythrocytosis that led to abnormal blood composition, short lifespan, and abnormal splenomegaly. Further, we identified 2,672 genes associated with splenomegaly by microarray analysis. These results could be useful in the development of dHuEPO-producing tg animals.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1477-7827-10-6","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T18:56:10Z","timestamp":1327949770000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aberrant phenotypes of transgenic mice expressing dimeric human erythropoietin"],"prefix":"10.1186","volume":"10","author":[{"given":"Seong-Jo","family":"Yun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purevjargal","family":"Naidansuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Woong","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cha-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tseeleema","family":"Nanjidsuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Hwa","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue-Yun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Taek","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan-Sik","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,27]]},"reference":[{"issue":"7","key":"940_CR1","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V78.7.1658.1658","volume":"78","author":"RS Stein","year":"1991","unstructured":"Stein RS, Abels RI, Krantz SB: Pharmacologic does of recombinant human erythropoietin in the treatment of myleodysplastic syndromes. Blood. 1991, 78 (7): 1658-1663.","journal-title":"Blood"},{"issue":"9","key":"940_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7326\/0003-4819-117-9-739","volume":"117","author":"DH Henry","year":"1992","unstructured":"Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med. 1992, 117 (9): 739-748.","journal-title":"Ann Intern Med"},{"issue":"2","key":"940_CR3","first-page":"97","volume":"15","author":"M Buemi","year":"2002","unstructured":"Buemi M, Aloisi C, Cavallaro E, Corica F, Floccari F, Grasso G, Lasco A, Pettinato G, Ruello A, Sturiale A, Frisina N: Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia. J Nephrol. 2002, 15 (2): 97-103.","journal-title":"J Nephrol"},{"issue":"933","key":"940_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/pmj.79.933.367","volume":"79","author":"T Ng","year":"2003","unstructured":"Ng T, Marx G, Littlewood T, Macdougall I: Recombinant erythropoietin in clinical practice. Postgrad Med J. 2003, 79 (933): 367-376. 10.1136\/pmj.79.933.367.","journal-title":"Postgrad Med J"},{"issue":"9539","key":"940_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0140-6736(06)69120-4","volume":"368","author":"IC Macdougall","year":"2006","unstructured":"Macdougall IC, Eckardt KU: Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia. Lancet. 2006, 368 (9539): 947-953. 10.1016\/S0140-6736(06)69120-4.","journal-title":"Lancet"},{"issue":"3","key":"940_CR6","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1182\/blood-2006-08-019083","volume":"109","author":"HF Bunn","year":"2007","unstructured":"Bunn HF: New agents that stimulate erythropoiesis. Blood. 2007, 109 (3): 868-873.","journal-title":"Blood"},{"issue":"12","key":"940_CR7","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1182\/blood.V97.12.3776","volume":"97","author":"B Dalle","year":"2001","unstructured":"Dalle B, Henri A, Rouyer-Fessard P, Bettan M, Scherman D, Beuzard Y, Payen E: Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo. Blood. 2001, 97 (12): 3776-3782. 10.1182\/blood.V97.12.3776.","journal-title":"Blood"},{"issue":"18","key":"940_CR8","doi-asserted-by":"publisher","first-page":"11173","DOI":"10.1074\/jbc.273.18.11173","volume":"273","author":"H Qiu","year":"1998","unstructured":"Qiu H, Belanger A, Yoon HWP, Bunn HF: Homodimerazation restores biological activity to an inactive erythropoietin mutant. J Biol Chem. 1998, 273 (18): 11173-11176. 10.1074\/jbc.273.18.11173.","journal-title":"J Biol Chem"},{"issue":"35","key":"940_CR9","doi-asserted-by":"publisher","first-page":"24773","DOI":"10.1074\/jbc.274.35.24773","volume":"274","author":"AJ Syktowski","year":"1999","unstructured":"Syktowski AJ, Lunn ED, Risinger MA, Davis KL: An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties. J Biol Chem. 1999, 274 (35): 24773-24778. 10.1074\/jbc.274.35.24773.","journal-title":"J Biol Chem"},{"issue":"11","key":"940_CR10","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V10112392","volume":"10","author":"IC Macdougall","year":"1999","unstructured":"Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Brown J, Egrie J: Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol. 1999, 10 (11): 2392-2395.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"940_CR11","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1210\/en.2007-0026","volume":"148","author":"F Fares","year":"2007","unstructured":"Fares F, Ganem S, Hajouj T, Agai E: Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin \u03b2-subunit to the coding sequence of human erythropoietin. Endocrinology. 2007, 148 (10): 5081-5087. 10.1210\/en.2007-0026.","journal-title":"Endocrinology"},{"issue":"2","key":"940_CR12","first-page":"69","volume":"29","author":"JJ Park","year":"2005","unstructured":"Park JJ, Lee HG, Nam IS, Park HJ, Kim MS, Chung YH, Naidansuren PJ, Kang HY, Lee PY, Park JG, Seong HH, Chang WK, Min KS: Biological activity of recombinant human erythropoietin (EPO) in vivo and in vitro. Reprod Dev Biol. 2005, 29 (2): 69-79.","journal-title":"Reprod Dev Biol"},{"issue":"2","key":"940_CR13","first-page":"77","volume":"33","author":"PJ Naidansuren","year":"2009","unstructured":"Naidansuren PJ, Min KS: Development and characterization of hyperglycosylated recombinant human erythropoietin (HGEPO). Reprod Dev Biol. 2009, 33 (2): 77-83.","journal-title":"Reprod Dev Biol"},{"issue":"4","key":"940_CR14","first-page":"289","volume":"34","author":"PJ Naidansuren","year":"2010","unstructured":"Naidansuren PJ, Min KS: Biological activity of human dimeric hyperglycosylated erythropoietin (dHGEPO) fusion proteins. Reprod Dev Biol. 2010, 34 (4): 289-297.","journal-title":"Reprod Dev Biol"},{"issue":"4-5","key":"940_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1023\/A:1008934912555","volume":"9","author":"LM Houdebine","year":"2000","unstructured":"Houdebine LM: Transgenic animal bioreactors. Transgenic Res. 2000, 9 (4-5): 305-312.","journal-title":"Transgenic Res"},{"issue":"6","key":"940_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0958-1669(02)00362-2","volume":"13","author":"LM Houdebine","year":"2002","unstructured":"Houdebine LM: Antibody manufacture in transgenic animals and comparisons with other systems. Curr Opin Biotechnol. 2002, 13 (6): 625-629. 10.1016\/S0958-1669(02)00362-2.","journal-title":"Curr Opin Biotechnol"},{"issue":"13","key":"940_CR17","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1073\/pnas.87.13.5178","volume":"87","author":"AL Archibald","year":"1990","unstructured":"Archibald AL, McClenaghan M, Hornsey V, Simons JP, Clark AJ: High-level expression of biologically active human 1-antitrypsin in the milk of transgenic mice. Proc Natl Acad Sci USA. 1990, 87 (13): 5178-5182. 10.1073\/pnas.87.13.5178.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"940_CR18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1182\/blood-2006-12-063602","volume":"110","author":"A Bogdanova","year":"2009","unstructured":"Bogdanova A, Mihov D, Lutz H, Saam B, Gassmann M, Vogel J: Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. Blood. 2009, 110 (2): 762-769.","journal-title":"Blood"},{"key":"940_CR19","doi-asserted-by":"publisher","first-page":"R947-R956","DOI":"10.1152\/ajpregu.00152.2006","volume":"291","author":"K Heinicke","year":"2006","unstructured":"Heinicke K, Baun O, Ogunshola OO, Vogel J, Stallmach T, Wolfer DP, Keller S, Weber K, Wagner PD, Gassmann M, Djonov V: Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am J Physiol Regul Integr Comp Physiol. 2006, 291: R947-R956-","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"940_CR20","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood-2003-01-0283","volume":"102","author":"J Vogel","year":"2003","unstructured":"Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W, Gassmann M: Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood. 2003, 102 (6): 2278-2284. 10.1182\/blood-2003-01-0283.","journal-title":"Blood"},{"issue":"3","key":"940_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jbiotec.2005.11.021","volume":"122","author":"JK Park","year":"2006","unstructured":"Park JK, Lee YK, Lee P, Chung HJ, Kim S, Lee HG, Seo MK, Han JH, Park CG, Kim HT, Kim YK, Min KS, Kim JH, Lee HT, Chang WK: Recombinant human erythropoietin produced in milk of transgenic pigs. J Biotechnol. 2006, 122 (3): 362-371. 10.1016\/j.jbiotec.2005.11.021.","journal-title":"J Biotechnol"},{"issue":"3","key":"940_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1262\/jrd.50.297","volume":"50","author":"KS Min","year":"2004","unstructured":"Min KS, Hiyama T, Seong HH, Hattori N, Tanaka S, Shiota K: Biological activities of tethered equine chorionic gonadotropin (eCG) and its deglycosylated mutants. J Reprod Dev. 2004, 50 (3): 297-304. 10.1262\/jrd.50.297.","journal-title":"J Reprod Dev"},{"issue":"5941","key":"940_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/306313a0","volume":"306","author":"B Hogan","year":"1983","unstructured":"Hogan B: Molecular biology, enhancers, chromosome position effects and transgenic mice. Nature. 1983, 306 (5941): 313-314. 10.1038\/306313a0.","journal-title":"Nature"},{"key":"940_CR24","unstructured":"Panther database. [http:\/\/www.pantherdb.org]"},{"key":"940_CR25","unstructured":"Primer3 software. [http:\/\/www.bioneer.co.kr\/tools\/]"},{"issue":"1","key":"940_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0093-691X(97)00408-1","volume":"49","author":"CA Ziomek","year":"1998","unstructured":"Ziomek CA: Commercialization of proteins produced in the mammary gland. Theriogenology. 1998, 49 (1): 139-144. 10.1016\/S0093-691X(97)00408-1.","journal-title":"Theriogenology"},{"issue":"8","key":"940_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1071\/RD08085","volume":"20","author":"X Song","year":"2008","unstructured":"Song X, Tai P, Yan J, Xu B, Chen X, Ouyang H, Zhang M, Xia G: Expression of regulation of lanosterol 14a-demethylase in mouse embryo and uterine during the peri-implantation period. Reprod Fertil Dev. 2008, 20 (8): 964-972. 10.1071\/RD08085.","journal-title":"Reprod Fertil Dev"},{"issue":"7","key":"940_CR28","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1073\/pnas.86.7.2301","volume":"86","author":"GL Semenza","year":"1989","unstructured":"Semenza GL, Traystman MD, Gearhart JD, Antonarakis SE: Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc Natl Acad Sci USA. 1989, 86 (7): 2301-2305. 10.1073\/pnas.86.7.2301.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"940_CR29","first-page":"107","volume":"6","author":"JL Villeval","year":"1992","unstructured":"Villeval JL, Metcalf D, Johnson GR: Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells. Leukemia. 1992, 6 (2): 107-115.","journal-title":"Leukemia"},{"issue":"5219","key":"940_CR30","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1126\/science.7604250","volume":"268","author":"JT Prchal","year":"1995","unstructured":"Prchal JT, Semenza GL, Sokol LP: Familial polycythemia. Science. 1995, 268 (5219): 1831-1832. 10.1126\/science.7604250.","journal-title":"Science"},{"issue":"10","key":"940_CR31","first-page":"2735","volume":"85","author":"A Madan","year":"1995","unstructured":"Madan A, Lin C, Hatch SL, Curtin PT: Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood. 1995, 85 (10): 2735-2741.","journal-title":"Blood"},{"issue":"4","key":"940_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.1365-2141.1998.01081.x","volume":"103","author":"J Kochling","year":"1998","unstructured":"Kochling J, Curtin PT, Madan A: Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice. Br J Haematol. 1998, 103 (4): 960-968. 10.1046\/j.1365-2141.1998.01081.x.","journal-title":"Br J Haematol"},{"issue":"2","key":"940_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood.V97.2.536","volume":"97","author":"KF Wagner","year":"2001","unstructured":"Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B, Gembruch U, Schramm U, Jelkmann W, Gassmann M, Fandrey J: Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood. 2001, 97 (2): 536-542. 10.1182\/blood.V97.2.536.","journal-title":"Blood"},{"issue":"1","key":"940_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S1079-9796(03)00016-0","volume":"30","author":"A Madan","year":"2003","unstructured":"Madan A, Lin C, Wang Z, Curtin PT: Autocrine stimulation by erythropoietin in transgenic mice results in erythroid proliferation without neoplastic transformation. Blood Cells Mol Dis. 2003, 30 (1): 82-89. 10.1016\/S1079-9796(03)00016-0.","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"940_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1016-8478(23)07384-3","volume":"23","author":"MO Kim","year":"2007","unstructured":"Kim MO, Kim SH, Shin MJ, Lee DB, Kim TW, Kim KS, Ha JH, Lee S, Park YB, Kim SJ, Ryoo ZY: Human erythropoietin induces lung failure and erythrocytosis in transgenic mice. Mol Cells. 2007, 23 (1): 17-22.","journal-title":"Mol Cells"},{"issue":"2","key":"940_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejogrb.2008.04.002","volume":"140","author":"B Toth","year":"2008","unstructured":"Toth B, Fischl A, Scholz C, Kunze S, Friese K, Jeschke U: Erythropoietin and erythropoietin receptor expression in normal and disturbed pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008, 140 (2): 192-200. 10.1016\/j.ejogrb.2008.04.002.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"940_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1515\/JPM.2004.045","volume":"32","author":"KA Teramo","year":"2004","unstructured":"Teramo KA, Hiilesmaa VK, Schwartz R, Clemons GK, Widness JA: Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension. J Perinat Med. 2004, 32 (3): 240-247. 10.1515\/JPM.2004.045.","journal-title":"J Perinat Med"},{"issue":"3","key":"940_CR38","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1128\/MCB.10.3.930","volume":"10","author":"GL Semenza","year":"1990","unstructured":"Semenza GL, Dureza RD, Traystman MD, Gearhart JD, Antonarakis SE: Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements. Mol Cell Biol. 1990, 10 (3): 930-988.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"940_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF01973981","volume":"3","author":"I Barash","year":"1994","unstructured":"Barash I, Faerman A, Ratovitsky T, Puzis R, Nathan M, Hurwitz DR, Shani M: Ectopic expression of \u03b2-lactoglobulin\/human serum albumin fusion genes in transgenic mice: hormonal regulation and in situ localization. Transgenic Res. 1994, 3 (3): 141-151. 10.1007\/BF01973981.","journal-title":"Transgenic Res"},{"issue":"5","key":"940_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1051\/rnd:19960511","volume":"36","author":"M Massoud","year":"1996","unstructured":"Massoud M, Atta J, Thepot D, Pointu H, Stinnakre MG, Theron MC, Lopez C, Houdebine LM: The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. Reprod Nutr Dev. 1996, 36 (5): 555-563. 10.1051\/rnd:19960511.","journal-title":"Reprod Nutr Dev"},{"issue":"3","key":"940_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.blre.2008.10.001","volume":"23","author":"AL Pozo","year":"2009","unstructured":"Pozo AL, Godfrey EM, Bowles KM: Splenomegaly: investigation, diagnosis and management. Blood Reviews. 2009, 23 (3): 105-111. 10.1016\/j.blre.2008.10.001.","journal-title":"Blood Reviews"},{"issue":"2","key":"940_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000040975","volume":"102","author":"J Swaroop","year":"1999","unstructured":"Swaroop J, O'Reilly RA: Splenomegaly at a university hospital compared to a nearby county hospital in 317 patients. Acta Haematol. 1999, 102 (2): 83-88. 10.1159\/000040975.","journal-title":"Acta Haematol"},{"issue":"2","key":"940_CR43","first-page":"88","volume":"169","author":"RA O'Reilly","year":"1998","unstructured":"O'Reilly RA: Splenomegaly in 2505 patients at a large university medical centre from 1913 to 1995. 1963 to 1995: 449 patients. West J Med. 1998, 169 (2): 88-97.","journal-title":"West J Med"},{"issue":"1","key":"940_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/shem.2001.23043","volume":"38","author":"TC Pearson","year":"2001","unstructured":"Pearson TC: Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol. 2001, 38 (1): 21-24. 10.1053\/shem.2001.23043.","journal-title":"Semin Hematol"},{"issue":"1","key":"940_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1262\/jrd.18123","volume":"53","author":"K Hashizume","year":"2007","unstructured":"Hashizume K: Analysis of uteroplacental-specific molecules and their functions during implantation and placentation in the bovine. J Reprod Dev. 2007, 53 (1): 1-11. 10.1262\/jrd.18123.","journal-title":"J Reprod Dev"},{"issue":"6","key":"940_CR46","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1210\/endo.143.6.8885","volume":"143","author":"LC Kao","year":"2002","unstructured":"Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, Osteen K, Taylor RN, Lessey BA, Giudice LC: Global gene profiling in human endometrium during the window of implantation. Endocrinology. 2002, 143 (6): 2119-2138. 10.1210\/en.143.6.2119.","journal-title":"Endocrinology"},{"issue":"41","key":"940_CR47","doi-asserted-by":"publisher","first-page":"15212","DOI":"10.1073\/pnas.0607098103","volume":"103","author":"K Wada","year":"2006","unstructured":"Wada K, Howard JT, McConnell P, Whitney O, Lints T, Rivas MV, Horita H, Patterson MA, White SA, Scharff C, Haesler S, Zhao S, Sakaguchi H, Hagiwara M, Shiraki T, Hirozane-Kishikawa T, Skene P, Hayashizaki Y, Carninci P, Jarvis ED: A molecular neuroethological approach for identifying and characterization a cascade of behaviorally regulated genes. Proc Natl Acad Sci USA. 2006, 103 (41): 15212-15217. 10.1073\/pnas.0607098103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"940_CR48","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ng1034","volume":"32","author":"RF Chuaqui","year":"2002","unstructured":"Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V, Emmert-Buck MR: Postanalysis follow-up and validation of microarray experiments. Nature Genet. 2002, 32: 509-514. 10.1038\/ng1034.","journal-title":"Nature Genet"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T17:26:55Z","timestamp":1713461215000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-10-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-10-6","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,27]]},"assertion":[{"value":"22 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}